![Erin Lavelle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erin Lavelle
Direttore/Membro del Consiglio presso
JADE BIOSCIENCES, INC.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Erin M.
Lavelle is currently an Independent Director at Avalyn Pharma, Inc. since 2024, an Independent Director at Jade Biosciences, Inc. starting in 2025, and a Director at Jade Biosciences, Inc. (United States) since 2024.
Former roles include Director at Vitaeris, Inc., Independent Director at Neoleukin Therapeutics, Inc., General Manager at Amgen, Inc. from 2017 to 2018, Chief Operating Officer at Lundbeck Seattle BioPharmaceuticals, Inc. from 2018 to 2020, and Executive VP, Chief Operating & Financial Officer at Climb Bio, Inc. from 2020 to 2023.
Education includes an undergraduate degree from Yale University conferred in 1998.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AVALYN PHARMA INC -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Erin Lavelle
| Società | Posizione | Inizio |
|---|---|---|
| JADE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 28/04/2025 |
| AVALYN PHARMA INC. | Direttore/Membro del Consiglio | 01/07/2024 |
Precedenti posizioni note di Erin Lavelle
| Società | Posizione | Fine |
|---|---|---|
| CLIMB BIO, INC. | Direttore Finanziario/CFO | 10/03/2023 |
| ALDER BIOPHARMACEUTICALS, INC. | Direttore operativo | 01/02/2020 |
| AMGEN INC. | Corporate Officer/Principal | 01/03/2018 |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Direttore/Membro del Consiglio | - |
| NEUROGENE INC. | Direttore/Membro del Consiglio | - |
Formazione di Erin Lavelle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
82
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
